Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
03/2010
03/17/2010CN101675073A Improvement of factor viii polypeptide titers in cell cultures
03/17/2010CN101675072A Potent and selective mediators of cholesterol efflux
03/17/2010CN101675071A modified interferon beta polypeptides and their uses
03/17/2010CN101675070A Canine transient receptor potential v2 (ctrpv2) and methods of screening for trpv2 channel modulators
03/17/2010CN101675068A Novel method and compositions
03/17/2010CN101675067A Modifications of peptide compositions to increase stability and delivery efficiency
03/17/2010CN101671713A Kringle 5 gene-containing engineered bacterium fermentation process and kringle 5 protein purification process
03/17/2010CN101671681A Novel bacillus thuringiensis crystal polypeptides, polynucleotides, and compositions thereof
03/17/2010CN101671680A Novel bacillus thuringiensis crystal polypeptides, polynucleotides, and compositions thereof
03/17/2010CN101671679A Resistance-relevant gene and applications of radiation-resistant cocci
03/17/2010CN101671678A Halimodendron halodendron DREB transcription factor cDNA sequence, expression carrier and application thereof
03/17/2010CN101671677A Peanut aquaporin gene AhAQ1 and coded protein and gene cloning method thereof
03/17/2010CN101671676A Peanut C2H2 type salt-resistance zine finger protein gene AhZFP1 and coded protein and gene cloning method thereof
03/17/2010CN101671675A Method for cloning, identifying and expressing fusion and non-fusion genes of angiostatin Kringle 5
03/17/2010CN101671391A Rhodamine B artificial antigen and preparation method and application thereof
03/17/2010CN101671390A Human interferon alpha derivatives and preparation and use of pegylated products thereof
03/17/2010CN101671389A Erythrocyte generating characteristic-free erythropoietin with nervous protecting function and application thereof
03/17/2010CN101671388A Blood brain barrier penetrable erythropoietin (EPO) and application thereof
03/17/2010CN101671387A Trichinella spiralis and tumor cell associated antigen protein and preparation method and medical application thereof
03/17/2010CN101671345A Curcumol hapten and artificial antigen as well as preparation method thereof
03/17/2010CN101671335A Cytotoxins, prodrugs, linkers and stabilizers useful therefor
03/17/2010CN101670101A Attenuated live vaccine
03/17/2010CN100594037C Complement receptor 2 targeted complement modulators
03/16/2010US7678893 Fluorescent proteins from Copepoda species and methods for using same
03/16/2010US7678889 monoclonal antibody for identifying, diagnosing, monitoring, staging, imaging and treating ovarian cancer and noncancerous disease states in the ovary
03/16/2010US7678888 preparing a powdered form of a protein by mixing a solution of the protein with inulin and tagatose, and drying the mixture; stable at room temperature; Blood substitutes
03/16/2010US7678887 Identification and cloning of a novel human gene, RET16, involved in the intracellular signaling cascade
03/16/2010US7678886 increased recombinant protein expression levels, solubility, soluble expression and stability, lower immunogenicity, and improved pharmacokinetics and/or pharmacodynamics
03/16/2010US7678885 Recombinant bone morphogenetic protein heterodimers, compositions and methods of use
03/16/2010US7678884 Biologically active peptide and agent containing the same
03/16/2010US7678883 for the generation of insoluble fusion peptides; used for the expression and recovery of any bioactive peptides and proteins that are recombinantly expressed
03/16/2010US7678769 Hepatocyte growth factor receptor splice variants and methods of using same
03/16/2010US7678767 Glue compositions for lung volume reduction
03/16/2010US7678582 Assays for preimplantation factor and preimplantation factor peptides
03/16/2010US7678558 Method for overexpression of zwitterionic polysaccharides
03/16/2010US7678544 ADAM12, a novel marker for abnormal cell function
03/16/2010US7678540 Biomimetic chemotaxis receptor-signal complex for use in identifying modulators of B-cell and T-cell receptor signaling pathways; immunotherapy
03/16/2010US7678392 Colour reduction in canola protein isolate
03/16/2010US7678380 Cosmetic treatment method for fighting against skin ageing effects
03/16/2010US7678375 Fusion proteins of Mycobacterium tuberculosis
03/16/2010US7678374 Viral vectors expressing fusion of viral large envelope protein and protein of interest
03/16/2010US7678372 Tyrosine kinase inhibitors; anticancer agents; genetic engineered protein
03/16/2010CA2423616C Chemokine mutants in the treatment of multiple sclerosis
03/16/2010CA2422216C Method for the production of vitamin k-dependent proteins
03/16/2010CA2376986C Method for purification of proteins
03/16/2010CA2368617C Hydrogel-forming system with hydrophobic and hydrophilic components
03/16/2010CA2340422C Method for producing yeast expressed hpv types 6 and 16 capsid proteins
03/16/2010CA2191577C Method for treating and preventing atherosclerosis
03/11/2010WO2010028264A1 Methods and compositions for identifying modulators of anti-tetherin activity to inhibit propagation of viruses
03/11/2010WO2010028066A2 Cd133 epitopes
03/11/2010WO2010027857A2 Methods, microorganisms, and compositions for plant biomass processing
03/11/2010WO2010027827A2 Targeted costimulatory polypeptides and methods of use to treat cancer
03/11/2010WO2010027818A2 Conserved hemagglutinin epitope, antibodies to the epitope, and methods of use
03/11/2010WO2010027736A2 Antimicrobial protein compositions and production therefor from marine bacteria
03/11/2010WO2010027729A2 Gonococcal vaccines
03/11/2010WO2010027473A2 Immunogenic escherichia coli heat stable enterotoxin
03/11/2010WO2010027022A1 Bacterium capable of producing l-amino acid, and method for producing l-amino acid
03/11/2010WO2010026473A2 Pta072 protein
03/11/2010WO2010026432A1 Method for purifying protein complexes
03/11/2010WO2010026377A1 Diabetes t cell receptors
03/11/2010WO2010026346A1 Stable cell clone expressing a prion
03/11/2010WO2010026219A2 New tomato ethylene response factors and uses thereof
03/11/2010WO2010026165A1 Novel melanoma antigen peptide and uses thereof
03/11/2010WO2010025964A1 Vaccine comprising protein nmbo964 from meisseria meningitidis
03/11/2010WO2010025555A1 Periostin-induced pancreatic regeneration
03/11/2010WO2010025530A1 Proteic acid polymer, production processes, use of proteic acid polymer, pharmaceutical composition and method of treatment
03/11/2010WO2010007497A3 Glutamate decarboxylase (gad) transgenic plants that exhibit altered plant architecture
03/11/2010WO2010007496A3 Glutamate decarboxylase (gad) transgenic plants with enhanced nitrogen uptake and utilisation
03/11/2010WO2010007144A3 Mutated netrin-4 proteins, fragments thereof and their uses as drugs
03/11/2010WO2010006732A3 Brassica plant comprising a mutant indehiscent allelle
03/11/2010WO2010004512A3 Dicarba-analgues of octreotide
03/11/2010WO2010003032A8 Recombinant human parainfluenza type 1 viruses (hpiv1s) containing mutations in or deletion of the c protein are attenuated in african green monkeys and in ciliated human airway epithelial cells and are potential vaccine candidates for hpiv1
03/11/2010WO2010002989A3 Vaccines comprising pasteurella multocida recombinant filamentous hemagglutinin peptides
03/11/2010WO2009155484A3 Compositions and methods of use of orf1358 from beta-hemolytic streptococcal strains
03/11/2010WO2009155476A3 Compositions and methods of use of orf 554 from beta hemolytic streptococcal strains
03/11/2010WO2009149171A3 Fgf21 mutants and uses thereof
03/11/2010WO2009146463A3 Variant hhip1 protein and methods and uses thereof
03/11/2010WO2009143489A3 Modulation of angiogenesis by a-beta peptide fragments
03/11/2010WO2009143133A3 Compositions and methods to protect cells by blocking entry of pathogen proteins
03/11/2010WO2009142727A3 Sequence modified calcitonin gene related peptides (cgrp)
03/11/2010WO2009130709A3 A non-recombinant membrane antigen, a diagnostic kit thereof and process for detection of visceral leishmaniasis and pkdl
03/11/2010WO2009128949A3 Compositions of dengue viral proteins and methods of use
03/11/2010WO2009127441A3 Transcription factors involved in drought stress in plants
03/11/2010WO2009122227A3 Treating cerebrovascular diseases with erythropoietin and granulocyte-colony stimulating factor jointly
03/11/2010WO2009115809A3 Thyroid stimulating hormone fusion proteins
03/11/2010WO2009098683A3 Insulin-like gene of prawns and uses thereof
03/11/2010WO2009095646A3 Peptides from factor viii
03/11/2010WO2009069133A3 Methods for the treatment of radiation or chemotherapy-induced tissue damage
03/11/2010WO2008114020A9 Mutant g-protein coupled receptors and methods for selecting them
03/11/2010US20100064393 Bacillus liceniformis chromosome
03/11/2010US20100064385 Crop grain filling gene gif1 and the applications thereof
03/11/2010US20100064384 Method for modifying the atp/adp ratio in cells
03/11/2010US20100064383 Novel gene encoding MYB transcription factor involved in proanthocyanidin synthesis
03/11/2010US20100063261 Affinity chromatography matrices and methods of making and using the same
03/11/2010US20100063260 Whitefly Ecdysone Receptor Antibody
03/11/2010US20100063259 Compositions and methods for diagnosing or treating psoriasis
03/11/2010US20100063256 Novel immunoglobulin-binding proteins with improved specificity
03/11/2010US20100063255 Canola Protein Isolate Compositions
03/11/2010US20100063254 Process for obtaining legume protein fractions of moderate molecular weight, legume protein fractions and use thereof
03/11/2010US20100063253 Long-Lasting Collagen and Manufacturing Method thereof
1 ... 535 536 537 538 539 540 541 542 543 544 545 546 547 548 549 550 551 552 553 554 555 ... 2916